Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitorsAlina Iulia Chiriac, Florian Kloss, Jonas Krämer, et al.Chemmedchem|July 26, 2022
Thieno[2,3-d]pyrimidine-Core Compounds Show Activity against Clinically Relevant Gram-Positive BacteriaOlga Riabova, Anna Egorova, Alexander Lepioshkin, et al.Chemistry, an Asian Journal|September 2, 2011
Metal-free 1,5-regioselective azide-alkyne [3+2]-cycloadditionFlorian Kloss, Uwe Köhn, Burkhard O Jahn, et al.Jac-Antimicrobial Resistance|August 20, 2025
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of TuberculosisWandini Lutchmun, Norbert Heinrich, Elin M Svensson, et al.Organic Letters|March 28, 2020
Modular Solid-Phase Synthesis of Antiprotozoal Barnesin DerivativesDávid Roman, Luka Raguž, François Keiff, et al.Journal of Biotechnology|June 12, 2021
Host nutrition-based approach for biotechnological production of the antifungal cyclic lipopeptide jagaricinNicolas Schlosser, Jordi Espino-Martínez, Florian Kloss, et al.Biotechnology Journal|March 18, 2025
Pilot Scale Production of a F<sub>420</sub> Precursor Under Microaerobic ConditionsAnnika Lenić, Bettina Bardl, Florian Kloss, et al.Journal of Medicinal Chemistry|May 3, 2022
Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of BenzothiazinonesSebastian Schieferdecker, Freddy A Bernal, K Philip Wojtas, et al.Engineering in Life Sciences|December 14, 2022
Scalable downstream method for the cyclic lipopetide jagaricinJakob Stein, Nicolas Schlosser, Bettina Bardl, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 18, 2019
Metal-Free Aryl Cross-Coupling Directed by Traceless LinkersVeit G Haensch, Toni Neuwirth, Johannes Steinmetzer, et al.Pageof 4